Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist
about
Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models.Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function.Insulin-like growth factor (IGF)-I obliterates the pregnancy-associated protection against mammary carcinogenesis in rats: evidence that IGF-I enhances cancer progression through estrogen receptor-alpha activation via the mitogen-activated protein kDoes growth hormone cause cancer?Genetic Regulation of Female Sexual Maturation and Longevity Through Circulating IGF1Insulin and insulin-like growth factor signalling in neoplasiaEpidemiological and molecular mechanisms aspects linking obesity and cancer.Phase I trial of combination of FOLFIRI and pasireotide, a somatostatin analogue, in advanced gastrointestinal malignancies.Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.Parity-induced decrease in systemic growth hormone alters mammary gland signaling: a potential role in pregnancy protection from breast cancer.The GH/IGF-1 axis in ageing and longevityInhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approachMechanisms by which IGF-I may promote cancerInsulin-like growth factors and neoplasia.GH modulates hepatic epidermal growth factor signaling in the mouse.Reduced susceptibility to azoxymethane-induced aberrant crypt foci formation and colon cancer in growth hormone deficient ratsElevated GH/IGF-I promotes mammary tumors in high-fat, but not low-fat, fed miceSuccinate dehydrogenase-deficient gastrointestinal stromal tumors.Visceral adiposity, insulin resistance and cancer risk.The role of growth hormone-receptor antagonism in relation to acromegaly.Growth hormone modulation of EGF-induced PI3K-Akt pathway in mice liverThe contribution of growth hormone to mammary neoplasiaAssociations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancerGrowth hormone excess and the development of growth hormone receptor antagonists.Human metastatic melanoma cell lines express high levels of growth hormone receptor and respond to GH treatment.Evaluation of growth hormone (GH) action in mice: discovery of GH receptor antagonists and clinical indications.Pegvisomant: current and potential novel therapeutic applications.Germ line knockout of IGFBP-3 reveals influences of the gene on mammary gland neoplasia.Role of the growth hormone–IGF-1 axis in cancer
P2860
Q24645123-D38E7C76-6854-4C1F-89DC-50DDA2A44F94Q24800144-ABAF9AD7-2DF4-4B29-859B-347115D268C4Q24806371-B31EBC71-5B43-45AA-9373-D6EC1FA8B691Q28293263-29C834CF-6612-4836-8CCD-FB08796BAF70Q28647905-3CA5E971-0F2C-4E7C-BAE5-FE6B71F921DFQ29619495-260A7652-C125-4C4B-B090-EE883292E0D7Q30377470-3E48E2A7-0108-490C-9EFC-386CF46E33B4Q33425196-822035E2-E63E-4C6D-9046-D01B9FAB0446Q33569159-C9CED12C-7232-444D-B2FD-6497785BD3FCQ33708005-FDB44094-1020-4A08-B690-590AEC6B50E3Q33817029-74DBE620-B616-40AF-9E1B-2836D5ACB4ACQ33925323-527E6DBD-31BA-4BD6-8D80-B5A30D2D0DA3Q34180961-09AD2C2F-BCE3-4373-9219-1DF1E8043F51Q34330521-D95E0829-7306-460F-B32B-BD1A234DE995Q34398594-9457CE21-99F9-4B60-BF79-843B3DAC9A91Q34420887-3D9C848A-B729-4F03-A8E5-6EF3158C527FQ34434910-DA694C74-25A7-4E26-92B8-D955F4A76A2EQ34668378-754ED2D6-3661-405C-9575-59BF7E51F997Q35133640-E9819A85-A953-44C2-8456-EEF205DC0A69Q35925517-C6775280-9E88-4E21-961B-9A126BD863C9Q36739639-1C5D97D0-D6BB-40C2-A87A-B94A2AFBA780Q37078157-68EEF6FE-68BC-4560-AE1F-CC6254B51BD4Q37151431-C322B075-37BA-4859-AC74-04F43F06AB0AQ37212629-0DBBD783-D94B-4C43-9FF5-7FDE9C652A28Q37374857-62CE6971-6CC4-4945-AF03-5582ECB1E2A4Q37619460-310CBEDC-AFAB-424F-987E-944B6E83CD17Q37633543-848FC57E-BC25-4B22-843A-447E00B4C229Q51062416-0D1316EA-4FBE-4562-8247-880C456E3145Q57252658-79836A9B-B686-4469-B688-D1D64014B052
P2860
Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Reduced mammary gland carcinog ...... ng a growth hormone antagonist
@ast
Reduced mammary gland carcinog ...... ng a growth hormone antagonist
@en
Reduced mammary gland carcinog ...... ng a growth hormone antagonist
@nl
type
label
Reduced mammary gland carcinog ...... ng a growth hormone antagonist
@ast
Reduced mammary gland carcinog ...... ng a growth hormone antagonist
@en
Reduced mammary gland carcinog ...... ng a growth hormone antagonist
@nl
prefLabel
Reduced mammary gland carcinog ...... ng a growth hormone antagonist
@ast
Reduced mammary gland carcinog ...... ng a growth hormone antagonist
@en
Reduced mammary gland carcinog ...... ng a growth hormone antagonist
@nl
P2093
P356
P1476
Reduced mammary gland carcinog ...... ng a growth hormone antagonist
@en
P2093
J J Kopchick
M J Blouin
P2888
P304
P356
10.1054/BJOC.2001.1895
P407
P577
2001-08-03T00:00:00Z
P5875
P6179
1050486964